retatrutide protocol reddit Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide Maintenance: Strategies for Long-Term

Further tests on obese rats supported the idea that tesofensine could reduce body weight, so NeuroSearch decided to focus on developing it as an oral anti-obesity drug

Quick Answer: GLP-1 receptor agonists do not directly cause frequent urination as a pharmacological effect, though some patients may experience urinary changes due to indirect factors like weight loss, improved glycemic control, or hydration changes

These medications affect gastric emptying and glucose metabolism , which may pose risks during anaesthesia

- Snacks - I don't keep a lot of snacks in the house, but 2-3x a week I would go to Publix for some snacks

Some researchers are raising additional concerns about pancreatic cancer potential risk and GLP-1 RAs

Allurion to increase focus on low-dose GLP-1 combination therapy and muscle mass maintenance owenhaskins Aug 6, 2025 3 min read Allurion Technologies has revealed a strategic direction with an increasing focus on low-dose GLP-1 combination therapy, muscle mass maintenance and US market entry